HealthEquity (NASDAQ:HQY) Given Outperform Rating at Barrington Research

Key Points

• Barrington Research has reiterated an "outperform" rating for HealthEquity (NASDAQ:HQY) with a price target of $125.00, indicating a potential upside of 41.58% from its previous close.
• The stock has garnered multiple positive ratings from analysts, with an average rating of "Buy" and a consensus target price of $117.82.
• HealthEquity's recent quarterly earnings surpassed expectations, reporting $0.97 EPS and revenues of $330.80 million, compared to estimates of $0.81 EPS and $322.25 million in revenue.

HealthEquity (NASDAQ:HQY - Get Free Report)'s stock had its "outperform" rating reiterated by Barrington Research in a report issued on Friday,Benzinga reports. They currently have a $125.00 price target on the stock. Barrington Research's price objective points to a potential upside of 41.58% from the company's previous close.

HQY has been the topic of a number of other reports. Raymond James Financial restated a "strong-buy" rating and set a $120.00 price target (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. The Goldman Sachs Group increased their price target on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. JMP Securities increased their price target on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $117.82.

HealthEquity Stock Up 0.4%

NASDAQ HQY opened at $88.29 on Friday. The firm has a market cap of $7.63 billion, a PE ratio of 64.45, a price-to-earnings-growth ratio of 1.36 and a beta of 0.54. HealthEquity has a one year low of $73.84 and a one year high of $116.65. The stock's 50 day simple moving average is $95.73 and its 200 day simple moving average is $95.99. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same period in the prior year, the company earned $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. As a group, sell-side analysts forecast that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other news, Director Jon Kessler sold 134,183 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.08, for a total value of $15,039,230.64. Following the transaction, the director directly owned 253,510 shares in the company, valued at $28,413,400.80. This trade represents a 34.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the transaction, the executive vice president owned 75,689 shares in the company, valued at $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 291,744 shares of company stock worth $32,705,007 in the last three months. Insiders own 1.50% of the company's stock.

Institutional Trading of HealthEquity

Hedge funds and other institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC increased its stake in shares of HealthEquity by 2.9% in the 2nd quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company's stock valued at $397,000 after purchasing an additional 108 shares in the last quarter. Advisors Asset Management Inc. increased its stake in HealthEquity by 4.7% during the 2nd quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company's stock worth $255,000 after buying an additional 110 shares in the last quarter. Ieq Capital LLC increased its stake in HealthEquity by 4.4% during the 1st quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock worth $260,000 after buying an additional 123 shares in the last quarter. Xponance Inc. increased its stake in HealthEquity by 1.1% during the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock worth $1,097,000 after buying an additional 136 shares in the last quarter. Finally, Coldstream Capital Management Inc. increased its stake in HealthEquity by 7.3% during the 2nd quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company's stock worth $212,000 after buying an additional 138 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.